Global Next Generation Probiotics Supply, Demand and Key Producers, 2026-2032
The global Next Generation Probiotics market size is expected to reach $ 946 million by 2032, rising at a market growth of 9.4% CAGR during the forecast period (2026-2032).
In 2025, global Next Generation Probiotics production reached approximately 6,206 Tons.The average price is approximately $80,000.Next Generation Probiotics refer to a class of functional microbial products developed based on human microbiome science. These strains are usually derived from the human gut or specific ecological niches and are developed through functional screening, mechanism verification, and engineering to achieve predictable, repeatable, and verifiable health or therapeutic effects.
Gross Profit Margin Levels Currently, there is no unified, publicly available, and comparable 'industry average gross profit margin' in the next-generation probiotic industry. This is because this sector includes prescription LBP/microbial drug companies, consumer-grade NGP brands, and a few manufacturing platform companies, with vastly different business models. Overall, the theoretical gross profit margin of this industry is not low, but the actual gross profit margin in the early stages is often significantly compressed by manufacturing complexity: on the one hand, many key strains are strict anaerobes, requiring extremely high conditions for cultivation, freeze-drying, packaging, and storage and transportation; on the other hand, research has indicated that cGMP production of engineered or highly complex symbiotic bacteria requires specialized anaerobic facilities, and the freeze-drying process can also lead to more than 50% activity loss. Adding to this the costs of GMP workshops, release testing, stability verification, clinical trials, and cold chain/dosage form development, the gross profit margin of prescription or clinical-stage companies before scaling up production is usually not as easily increased as in traditional health supplements. Industry experience shows that the gross profit margin is relatively moderate in the small-batch stage and gradually increases after scaling up production. Consumer-grade high-end NGP brands, due to their higher retail prices (e.g., Pendulum's core products are priced significantly higher than traditional mass-market probiotics), often have higher profit margins at the product level. However, marketing education and user acquisition costs also dilute profits. In summary, I tend to view this sector as follows: prescription/clinical companies are mostly in the ramp-up phase of gross margins, while consumer-grade high-end brands offer better profit margins. However, the key to consistently realizing high profit margins still depends on technological maturity, large-scale manufacturing capabilities, and compliance cost control.
Industry Drivers
The core driving force of the next-generation probiotic industry in the past two years has primarily come from the genuine validation of regulatory and clinical feasibility: the approval of REBYOTA and VOWST signifies that microbiome therapy has moved from the 'proof of concept' stage to the 'regulatory feasibility' stage, which has a significant positive impact on capital, pharmaceutical company collaborations, and supply chain expansion. Secondly, the number of pipelines and the scope of indications are expanding rapidly. IQVIA has pointed out that there are more than 150 microbiome therapy projects in clinical development globally, focusing on infections, immune systems, oncology, and cardiometabolic diseases. This indicates that industry demand is no longer limited to recurrent C. difficile but is extending to the larger market for chronic diseases and adjuvant cancer treatment. Thirdly, advancements in multi-omics, AI-based bacterial screening, functional microbiome alliance design, and standardized manufacturing technologies have significantly improved the feasibility of moving from 'discovering bacteria' to 'making it into a drug/product.' Fourthly, regulatory collaboration and standardization are also strengthening. Organizations such as MTIG have been continuously promoting cross-regional rule harmonization in recent years, which helps reduce uncertainty for companies in CMC, release standards, and clinical development. Finally, the consumer side is also simultaneously benefiting from rising demand for metabolic health, intestinal barrier, and weight management. Representative 'next-generation strains' such as Akkermansia are expanding this sector from pure pharmaceuticals to high-end consumer healthcare, forming a 'dual-engine' growth structure.
This report studies the global Next Generation Probiotics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next Generation Probiotics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next Generation Probiotics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next Generation Probiotics total production and demand, 2021-2032, (Tons)
Global Next Generation Probiotics total production value, 2021-2032, (USD Million)
Global Next Generation Probiotics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Next Generation Probiotics consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Next Generation Probiotics domestic production, consumption, key domestic manufacturers and share
Global Next Generation Probiotics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Next Generation Probiotics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Next Generation Probiotics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Next Generation Probiotics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seres Therapeutics (USA), Ferring Pharmaceuticals (Switzerland), Vedanta Biosciences (USA), Enterome (France), 4D Pharma (UK), Second Genome (USA), AOBiome (USA), Finch Therapeutics (USA), MaaT Pharma (France), BioGaia (Sweden), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next Generation Probiotics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Next Generation Probiotics Market, By Region:
1. How big is the global Next Generation Probiotics market?
2. What is the demand of the global Next Generation Probiotics market?
3. What is the year over year growth of the global Next Generation Probiotics market?
4. What is the production and production value of the global Next Generation Probiotics market?
5. Who are the key producers in the global Next Generation Probiotics market?
6. What are the growth factors driving the market demand?
In 2025, global Next Generation Probiotics production reached approximately 6,206 Tons.The average price is approximately $80,000.Next Generation Probiotics refer to a class of functional microbial products developed based on human microbiome science. These strains are usually derived from the human gut or specific ecological niches and are developed through functional screening, mechanism verification, and engineering to achieve predictable, repeatable, and verifiable health or therapeutic effects.
Gross Profit Margin Levels Currently, there is no unified, publicly available, and comparable 'industry average gross profit margin' in the next-generation probiotic industry. This is because this sector includes prescription LBP/microbial drug companies, consumer-grade NGP brands, and a few manufacturing platform companies, with vastly different business models. Overall, the theoretical gross profit margin of this industry is not low, but the actual gross profit margin in the early stages is often significantly compressed by manufacturing complexity: on the one hand, many key strains are strict anaerobes, requiring extremely high conditions for cultivation, freeze-drying, packaging, and storage and transportation; on the other hand, research has indicated that cGMP production of engineered or highly complex symbiotic bacteria requires specialized anaerobic facilities, and the freeze-drying process can also lead to more than 50% activity loss. Adding to this the costs of GMP workshops, release testing, stability verification, clinical trials, and cold chain/dosage form development, the gross profit margin of prescription or clinical-stage companies before scaling up production is usually not as easily increased as in traditional health supplements. Industry experience shows that the gross profit margin is relatively moderate in the small-batch stage and gradually increases after scaling up production. Consumer-grade high-end NGP brands, due to their higher retail prices (e.g., Pendulum's core products are priced significantly higher than traditional mass-market probiotics), often have higher profit margins at the product level. However, marketing education and user acquisition costs also dilute profits. In summary, I tend to view this sector as follows: prescription/clinical companies are mostly in the ramp-up phase of gross margins, while consumer-grade high-end brands offer better profit margins. However, the key to consistently realizing high profit margins still depends on technological maturity, large-scale manufacturing capabilities, and compliance cost control.
Industry Drivers
The core driving force of the next-generation probiotic industry in the past two years has primarily come from the genuine validation of regulatory and clinical feasibility: the approval of REBYOTA and VOWST signifies that microbiome therapy has moved from the 'proof of concept' stage to the 'regulatory feasibility' stage, which has a significant positive impact on capital, pharmaceutical company collaborations, and supply chain expansion. Secondly, the number of pipelines and the scope of indications are expanding rapidly. IQVIA has pointed out that there are more than 150 microbiome therapy projects in clinical development globally, focusing on infections, immune systems, oncology, and cardiometabolic diseases. This indicates that industry demand is no longer limited to recurrent C. difficile but is extending to the larger market for chronic diseases and adjuvant cancer treatment. Thirdly, advancements in multi-omics, AI-based bacterial screening, functional microbiome alliance design, and standardized manufacturing technologies have significantly improved the feasibility of moving from 'discovering bacteria' to 'making it into a drug/product.' Fourthly, regulatory collaboration and standardization are also strengthening. Organizations such as MTIG have been continuously promoting cross-regional rule harmonization in recent years, which helps reduce uncertainty for companies in CMC, release standards, and clinical development. Finally, the consumer side is also simultaneously benefiting from rising demand for metabolic health, intestinal barrier, and weight management. Representative 'next-generation strains' such as Akkermansia are expanding this sector from pure pharmaceuticals to high-end consumer healthcare, forming a 'dual-engine' growth structure.
This report studies the global Next Generation Probiotics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next Generation Probiotics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next Generation Probiotics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next Generation Probiotics total production and demand, 2021-2032, (Tons)
Global Next Generation Probiotics total production value, 2021-2032, (USD Million)
Global Next Generation Probiotics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Next Generation Probiotics consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Next Generation Probiotics domestic production, consumption, key domestic manufacturers and share
Global Next Generation Probiotics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Next Generation Probiotics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Next Generation Probiotics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Next Generation Probiotics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seres Therapeutics (USA), Ferring Pharmaceuticals (Switzerland), Vedanta Biosciences (USA), Enterome (France), 4D Pharma (UK), Second Genome (USA), AOBiome (USA), Finch Therapeutics (USA), MaaT Pharma (France), BioGaia (Sweden), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next Generation Probiotics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Next Generation Probiotics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Akkermansia
- Clostridium Species
- Bifidobacterium Species
- Others
- Live NGP
- Inactivated NGP
- Others
- Metabolic Health Targeted Therapy
- Intestinal Inflammation Targeted Therapy
- Immune Regulation Targeted Therapy
- Others
- Pharmaceuticals and Biotherapy Industry
- Dietary Supplements and Functional Foods Industry
- Food and Beverage Industry
- Others
- Seres Therapeutics (USA)
- Ferring Pharmaceuticals (Switzerland)
- Vedanta Biosciences (USA)
- Enterome (France)
- 4D Pharma (UK)
- Second Genome (USA)
- AOBiome (USA)
- Finch Therapeutics (USA)
- MaaT Pharma (France)
- BioGaia (Sweden)
- Yakult Honsha (Japan)
- Morinaga Milk Industry (Japan)
- DuPont (USA)
- Chr. Hansen (Denmark)
- Lallemand (Canada)
- Probi (Sweden)
- Novozymes (Denmark)
- Kerry Group (Ireland)
- ADM (USA)
- BGI Genomics (China)
- Joinn Laboratories (China)
- Jiangsu Wecare Probiotics (China)
- Angel Yeast (China)
- Evelo Biosciences (USA)
- BIFIDO (South Korea)
- Cell Biotech (South Korea)
- Synlogic (USA)
1. How big is the global Next Generation Probiotics market?
2. What is the demand of the global Next Generation Probiotics market?
3. What is the year over year growth of the global Next Generation Probiotics market?
4. What is the production and production value of the global Next Generation Probiotics market?
5. Who are the key producers in the global Next Generation Probiotics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Next Generation Probiotics Introduction
1.2 World Next Generation Probiotics Supply & Forecast
1.2.1 World Next Generation Probiotics Production Value (2021 & 2025 & 2032)
1.2.2 World Next Generation Probiotics Production (2021-2032)
1.2.3 World Next Generation Probiotics Pricing Trends (2021-2032)
1.3 World Next Generation Probiotics Production by Region (Based on Production Site)
1.3.1 World Next Generation Probiotics Production Value by Region (2021-2032)
1.3.2 World Next Generation Probiotics Production by Region (2021-2032)
1.3.3 World Next Generation Probiotics Average Price by Region (2021-2032)
1.3.4 North America Next Generation Probiotics Production (2021-2032)
1.3.5 Europe Next Generation Probiotics Production (2021-2032)
1.3.6 China Next Generation Probiotics Production (2021-2032)
1.3.7 Japan Next Generation Probiotics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next Generation Probiotics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next Generation Probiotics Major Market Trends
2 DEMAND SUMMARY
2.1 World Next Generation Probiotics Demand (2021-2032)
2.2 World Next Generation Probiotics Consumption by Region
2.2.1 World Next Generation Probiotics Consumption by Region (2021-2026)
2.2.2 World Next Generation Probiotics Consumption Forecast by Region (2027-2032)
2.3 United States Next Generation Probiotics Consumption (2021-2032)
2.4 China Next Generation Probiotics Consumption (2021-2032)
2.5 Europe Next Generation Probiotics Consumption (2021-2032)
2.6 Japan Next Generation Probiotics Consumption (2021-2032)
2.7 South Korea Next Generation Probiotics Consumption (2021-2032)
2.8 ASEAN Next Generation Probiotics Consumption (2021-2032)
2.9 India Next Generation Probiotics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Next Generation Probiotics Production Value by Manufacturer (2021-2026)
3.2 World Next Generation Probiotics Production by Manufacturer (2021-2026)
3.3 World Next Generation Probiotics Average Price by Manufacturer (2021-2026)
3.4 Next Generation Probiotics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Next Generation Probiotics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Next Generation Probiotics in 2025
3.5.3 Global Concentration Ratios (CR8) for Next Generation Probiotics in 2025
3.6 Next Generation Probiotics Market: Overall Company Footprint Analysis
3.6.1 Next Generation Probiotics Market: Region Footprint
3.6.2 Next Generation Probiotics Market: Company Product Type Footprint
3.6.3 Next Generation Probiotics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Next Generation Probiotics Production Value Comparison
4.1.1 United States VS China: Next Generation Probiotics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Next Generation Probiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Next Generation Probiotics Production Comparison
4.2.1 United States VS China: Next Generation Probiotics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Next Generation Probiotics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Next Generation Probiotics Consumption Comparison
4.3.1 United States VS China: Next Generation Probiotics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Next Generation Probiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Next Generation Probiotics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Next Generation Probiotics Production (2021-2026)
4.5 China Based Next Generation Probiotics Manufacturers and Market Share
4.5.1 China Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.5.3 China Based Manufacturers Next Generation Probiotics Production (2021-2026)
4.6 Rest of World Based Next Generation Probiotics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Next Generation Probiotics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Next Generation Probiotics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Akkermansia
5.2.2 Clostridium Species
5.2.3 Bifidobacterium Species
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Next Generation Probiotics Production by Type (2021-2032)
5.3.2 World Next Generation Probiotics Production Value by Type (2021-2032)
5.3.3 World Next Generation Probiotics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY LIVE BACTERIA STATUS
6.1 World Next Generation Probiotics Market Size Overview by Live Bacteria Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Live Bacteria Status
6.2.1 Live NGP
6.2.2 Inactivated NGP
6.2.3 Others
6.3 Market Segment by Live Bacteria Status
6.3.1 World Next Generation Probiotics Production by Live Bacteria Status (2021-2032)
6.3.2 World Next Generation Probiotics Production Value by Live Bacteria Status (2021-2032)
6.3.3 World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2032)
7 MARKET ANALYSIS BY CORE FUNCTIONAL TARGETING DIMENSIONS
7.1 World Next Generation Probiotics Market Size Overview by Core Functional Targeting Dimensions: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Core Functional Targeting Dimensions
7.2.1 Metabolic Health Targeted Therapy
7.2.2 Intestinal Inflammation Targeted Therapy
7.2.3 Immune Regulation Targeted Therapy
7.2.4 Others
7.3 Market Segment by Core Functional Targeting Dimensions
7.3.1 World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2021-2032)
7.3.2 World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2021-2032)
7.3.3 World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Next Generation Probiotics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceuticals and Biotherapy Industry
8.2.2 Dietary Supplements and Functional Foods Industry
8.2.3 Food and Beverage Industry
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Next Generation Probiotics Production by Application (2021-2032)
8.3.2 World Next Generation Probiotics Production Value by Application (2021-2032)
8.3.3 World Next Generation Probiotics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Seres Therapeutics (USA)
9.1.1 Seres Therapeutics (USA) Details
9.1.2 Seres Therapeutics (USA) Major Business
9.1.3 Seres Therapeutics (USA) Next Generation Probiotics Product and Services
9.1.4 Seres Therapeutics (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Seres Therapeutics (USA) Recent Developments/Updates
9.1.6 Seres Therapeutics (USA) Competitive Strengths & Weaknesses
9.2 Ferring Pharmaceuticals (Switzerland)
9.2.1 Ferring Pharmaceuticals (Switzerland) Details
9.2.2 Ferring Pharmaceuticals (Switzerland) Major Business
9.2.3 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product and Services
9.2.4 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Ferring Pharmaceuticals (Switzerland) Recent Developments/Updates
9.2.6 Ferring Pharmaceuticals (Switzerland) Competitive Strengths & Weaknesses
9.3 Vedanta Biosciences (USA)
9.3.1 Vedanta Biosciences (USA) Details
9.3.2 Vedanta Biosciences (USA) Major Business
9.3.3 Vedanta Biosciences (USA) Next Generation Probiotics Product and Services
9.3.4 Vedanta Biosciences (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Vedanta Biosciences (USA) Recent Developments/Updates
9.3.6 Vedanta Biosciences (USA) Competitive Strengths & Weaknesses
9.4 Enterome (France)
9.4.1 Enterome (France) Details
9.4.2 Enterome (France) Major Business
9.4.3 Enterome (France) Next Generation Probiotics Product and Services
9.4.4 Enterome (France) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Enterome (France) Recent Developments/Updates
9.4.6 Enterome (France) Competitive Strengths & Weaknesses
9.5 4D Pharma (UK)
9.5.1 4D Pharma (UK) Details
9.5.2 4D Pharma (UK) Major Business
9.5.3 4D Pharma (UK) Next Generation Probiotics Product and Services
9.5.4 4D Pharma (UK) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 4D Pharma (UK) Recent Developments/Updates
9.5.6 4D Pharma (UK) Competitive Strengths & Weaknesses
9.6 Second Genome (USA)
9.6.1 Second Genome (USA) Details
9.6.2 Second Genome (USA) Major Business
9.6.3 Second Genome (USA) Next Generation Probiotics Product and Services
9.6.4 Second Genome (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Second Genome (USA) Recent Developments/Updates
9.6.6 Second Genome (USA) Competitive Strengths & Weaknesses
9.7 AOBiome (USA)
9.7.1 AOBiome (USA) Details
9.7.2 AOBiome (USA) Major Business
9.7.3 AOBiome (USA) Next Generation Probiotics Product and Services
9.7.4 AOBiome (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 AOBiome (USA) Recent Developments/Updates
9.7.6 AOBiome (USA) Competitive Strengths & Weaknesses
9.8 Finch Therapeutics (USA)
9.8.1 Finch Therapeutics (USA) Details
9.8.2 Finch Therapeutics (USA) Major Business
9.8.3 Finch Therapeutics (USA) Next Generation Probiotics Product and Services
9.8.4 Finch Therapeutics (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Finch Therapeutics (USA) Recent Developments/Updates
9.8.6 Finch Therapeutics (USA) Competitive Strengths & Weaknesses
9.9 MaaT Pharma (France)
9.9.1 MaaT Pharma (France) Details
9.9.2 MaaT Pharma (France) Major Business
9.9.3 MaaT Pharma (France) Next Generation Probiotics Product and Services
9.9.4 MaaT Pharma (France) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 MaaT Pharma (France) Recent Developments/Updates
9.9.6 MaaT Pharma (France) Competitive Strengths & Weaknesses
9.10 BioGaia (Sweden)
9.10.1 BioGaia (Sweden) Details
9.10.2 BioGaia (Sweden) Major Business
9.10.3 BioGaia (Sweden) Next Generation Probiotics Product and Services
9.10.4 BioGaia (Sweden) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 BioGaia (Sweden) Recent Developments/Updates
9.10.6 BioGaia (Sweden) Competitive Strengths & Weaknesses
9.11 Yakult Honsha (Japan)
9.11.1 Yakult Honsha (Japan) Details
9.11.2 Yakult Honsha (Japan) Major Business
9.11.3 Yakult Honsha (Japan) Next Generation Probiotics Product and Services
9.11.4 Yakult Honsha (Japan) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Yakult Honsha (Japan) Recent Developments/Updates
9.11.6 Yakult Honsha (Japan) Competitive Strengths & Weaknesses
9.12 Morinaga Milk Industry (Japan)
9.12.1 Morinaga Milk Industry (Japan) Details
9.12.2 Morinaga Milk Industry (Japan) Major Business
9.12.3 Morinaga Milk Industry (Japan) Next Generation Probiotics Product and Services
9.12.4 Morinaga Milk Industry (Japan) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Morinaga Milk Industry (Japan) Recent Developments/Updates
9.12.6 Morinaga Milk Industry (Japan) Competitive Strengths & Weaknesses
9.13 DuPont (USA)
9.13.1 DuPont (USA) Details
9.13.2 DuPont (USA) Major Business
9.13.3 DuPont (USA) Next Generation Probiotics Product and Services
9.13.4 DuPont (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 DuPont (USA) Recent Developments/Updates
9.13.6 DuPont (USA) Competitive Strengths & Weaknesses
9.14 Chr. Hansen (Denmark)
9.14.1 Chr. Hansen (Denmark) Details
9.14.2 Chr. Hansen (Denmark) Major Business
9.14.3 Chr. Hansen (Denmark) Next Generation Probiotics Product and Services
9.14.4 Chr. Hansen (Denmark) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Chr. Hansen (Denmark) Recent Developments/Updates
9.14.6 Chr. Hansen (Denmark) Competitive Strengths & Weaknesses
9.15 Lallemand (Canada)
9.15.1 Lallemand (Canada) Details
9.15.2 Lallemand (Canada) Major Business
9.15.3 Lallemand (Canada) Next Generation Probiotics Product and Services
9.15.4 Lallemand (Canada) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Lallemand (Canada) Recent Developments/Updates
9.15.6 Lallemand (Canada) Competitive Strengths & Weaknesses
9.16 Probi (Sweden)
9.16.1 Probi (Sweden) Details
9.16.2 Probi (Sweden) Major Business
9.16.3 Probi (Sweden) Next Generation Probiotics Product and Services
9.16.4 Probi (Sweden) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Probi (Sweden) Recent Developments/Updates
9.16.6 Probi (Sweden) Competitive Strengths & Weaknesses
9.17 Novozymes (Denmark)
9.17.1 Novozymes (Denmark) Details
9.17.2 Novozymes (Denmark) Major Business
9.17.3 Novozymes (Denmark) Next Generation Probiotics Product and Services
9.17.4 Novozymes (Denmark) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Novozymes (Denmark) Recent Developments/Updates
9.17.6 Novozymes (Denmark) Competitive Strengths & Weaknesses
9.18 Kerry Group (Ireland)
9.18.1 Kerry Group (Ireland) Details
9.18.2 Kerry Group (Ireland) Major Business
9.18.3 Kerry Group (Ireland) Next Generation Probiotics Product and Services
9.18.4 Kerry Group (Ireland) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Kerry Group (Ireland) Recent Developments/Updates
9.18.6 Kerry Group (Ireland) Competitive Strengths & Weaknesses
9.19 ADM (USA)
9.19.1 ADM (USA) Details
9.19.2 ADM (USA) Major Business
9.19.3 ADM (USA) Next Generation Probiotics Product and Services
9.19.4 ADM (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 ADM (USA) Recent Developments/Updates
9.19.6 ADM (USA) Competitive Strengths & Weaknesses
9.20 BGI Genomics (China)
9.20.1 BGI Genomics (China) Details
9.20.2 BGI Genomics (China) Major Business
9.20.3 BGI Genomics (China) Next Generation Probiotics Product and Services
9.20.4 BGI Genomics (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 BGI Genomics (China) Recent Developments/Updates
9.20.6 BGI Genomics (China) Competitive Strengths & Weaknesses
9.21 Joinn Laboratories (China)
9.21.1 Joinn Laboratories (China) Details
9.21.2 Joinn Laboratories (China) Major Business
9.21.3 Joinn Laboratories (China) Next Generation Probiotics Product and Services
9.21.4 Joinn Laboratories (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Joinn Laboratories (China) Recent Developments/Updates
9.21.6 Joinn Laboratories (China) Competitive Strengths & Weaknesses
9.22 Jiangsu Wecare Probiotics (China)
9.22.1 Jiangsu Wecare Probiotics (China) Details
9.22.2 Jiangsu Wecare Probiotics (China) Major Business
9.22.3 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product and Services
9.22.4 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Wecare Probiotics (China) Recent Developments/Updates
9.22.6 Jiangsu Wecare Probiotics (China) Competitive Strengths & Weaknesses
9.23 Angel Yeast (China)
9.23.1 Angel Yeast (China) Details
9.23.2 Angel Yeast (China) Major Business
9.23.3 Angel Yeast (China) Next Generation Probiotics Product and Services
9.23.4 Angel Yeast (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Angel Yeast (China) Recent Developments/Updates
9.23.6 Angel Yeast (China) Competitive Strengths & Weaknesses
9.24 Evelo Biosciences (USA)
9.24.1 Evelo Biosciences (USA) Details
9.24.2 Evelo Biosciences (USA) Major Business
9.24.3 Evelo Biosciences (USA) Next Generation Probiotics Product and Services
9.24.4 Evelo Biosciences (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Evelo Biosciences (USA) Recent Developments/Updates
9.24.6 Evelo Biosciences (USA) Competitive Strengths & Weaknesses
9.25 BIFIDO (South Korea)
9.25.1 BIFIDO (South Korea) Details
9.25.2 BIFIDO (South Korea) Major Business
9.25.3 BIFIDO (South Korea) Next Generation Probiotics Product and Services
9.25.4 BIFIDO (South Korea) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 BIFIDO (South Korea) Recent Developments/Updates
9.25.6 BIFIDO (South Korea) Competitive Strengths & Weaknesses
9.26 Cell Biotech (South Korea)
9.26.1 Cell Biotech (South Korea) Details
9.26.2 Cell Biotech (South Korea) Major Business
9.26.3 Cell Biotech (South Korea) Next Generation Probiotics Product and Services
9.26.4 Cell Biotech (South Korea) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Cell Biotech (South Korea) Recent Developments/Updates
9.26.6 Cell Biotech (South Korea) Competitive Strengths & Weaknesses
9.27 Synlogic (USA)
9.27.1 Synlogic (USA) Details
9.27.2 Synlogic (USA) Major Business
9.27.3 Synlogic (USA) Next Generation Probiotics Product and Services
9.27.4 Synlogic (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Synlogic (USA) Recent Developments/Updates
9.27.6 Synlogic (USA) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Next Generation Probiotics Industry Chain
10.2 Next Generation Probiotics Upstream Analysis
10.2.1 Next Generation Probiotics Core Raw Materials
10.2.2 Main Manufacturers of Next Generation Probiotics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Next Generation Probiotics Production Mode
10.6 Next Generation Probiotics Procurement Model
10.7 Next Generation Probiotics Industry Sales Model and Sales Channels
10.7.1 Next Generation Probiotics Sales Model
10.7.2 Next Generation Probiotics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Next Generation Probiotics Introduction
1.2 World Next Generation Probiotics Supply & Forecast
1.2.1 World Next Generation Probiotics Production Value (2021 & 2025 & 2032)
1.2.2 World Next Generation Probiotics Production (2021-2032)
1.2.3 World Next Generation Probiotics Pricing Trends (2021-2032)
1.3 World Next Generation Probiotics Production by Region (Based on Production Site)
1.3.1 World Next Generation Probiotics Production Value by Region (2021-2032)
1.3.2 World Next Generation Probiotics Production by Region (2021-2032)
1.3.3 World Next Generation Probiotics Average Price by Region (2021-2032)
1.3.4 North America Next Generation Probiotics Production (2021-2032)
1.3.5 Europe Next Generation Probiotics Production (2021-2032)
1.3.6 China Next Generation Probiotics Production (2021-2032)
1.3.7 Japan Next Generation Probiotics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next Generation Probiotics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next Generation Probiotics Major Market Trends
2 DEMAND SUMMARY
2.1 World Next Generation Probiotics Demand (2021-2032)
2.2 World Next Generation Probiotics Consumption by Region
2.2.1 World Next Generation Probiotics Consumption by Region (2021-2026)
2.2.2 World Next Generation Probiotics Consumption Forecast by Region (2027-2032)
2.3 United States Next Generation Probiotics Consumption (2021-2032)
2.4 China Next Generation Probiotics Consumption (2021-2032)
2.5 Europe Next Generation Probiotics Consumption (2021-2032)
2.6 Japan Next Generation Probiotics Consumption (2021-2032)
2.7 South Korea Next Generation Probiotics Consumption (2021-2032)
2.8 ASEAN Next Generation Probiotics Consumption (2021-2032)
2.9 India Next Generation Probiotics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Next Generation Probiotics Production Value by Manufacturer (2021-2026)
3.2 World Next Generation Probiotics Production by Manufacturer (2021-2026)
3.3 World Next Generation Probiotics Average Price by Manufacturer (2021-2026)
3.4 Next Generation Probiotics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Next Generation Probiotics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Next Generation Probiotics in 2025
3.5.3 Global Concentration Ratios (CR8) for Next Generation Probiotics in 2025
3.6 Next Generation Probiotics Market: Overall Company Footprint Analysis
3.6.1 Next Generation Probiotics Market: Region Footprint
3.6.2 Next Generation Probiotics Market: Company Product Type Footprint
3.6.3 Next Generation Probiotics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Next Generation Probiotics Production Value Comparison
4.1.1 United States VS China: Next Generation Probiotics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Next Generation Probiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Next Generation Probiotics Production Comparison
4.2.1 United States VS China: Next Generation Probiotics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Next Generation Probiotics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Next Generation Probiotics Consumption Comparison
4.3.1 United States VS China: Next Generation Probiotics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Next Generation Probiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Next Generation Probiotics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Next Generation Probiotics Production (2021-2026)
4.5 China Based Next Generation Probiotics Manufacturers and Market Share
4.5.1 China Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.5.3 China Based Manufacturers Next Generation Probiotics Production (2021-2026)
4.6 Rest of World Based Next Generation Probiotics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Next Generation Probiotics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Next Generation Probiotics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Next Generation Probiotics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Akkermansia
5.2.2 Clostridium Species
5.2.3 Bifidobacterium Species
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Next Generation Probiotics Production by Type (2021-2032)
5.3.2 World Next Generation Probiotics Production Value by Type (2021-2032)
5.3.3 World Next Generation Probiotics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY LIVE BACTERIA STATUS
6.1 World Next Generation Probiotics Market Size Overview by Live Bacteria Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Live Bacteria Status
6.2.1 Live NGP
6.2.2 Inactivated NGP
6.2.3 Others
6.3 Market Segment by Live Bacteria Status
6.3.1 World Next Generation Probiotics Production by Live Bacteria Status (2021-2032)
6.3.2 World Next Generation Probiotics Production Value by Live Bacteria Status (2021-2032)
6.3.3 World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2032)
7 MARKET ANALYSIS BY CORE FUNCTIONAL TARGETING DIMENSIONS
7.1 World Next Generation Probiotics Market Size Overview by Core Functional Targeting Dimensions: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Core Functional Targeting Dimensions
7.2.1 Metabolic Health Targeted Therapy
7.2.2 Intestinal Inflammation Targeted Therapy
7.2.3 Immune Regulation Targeted Therapy
7.2.4 Others
7.3 Market Segment by Core Functional Targeting Dimensions
7.3.1 World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2021-2032)
7.3.2 World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2021-2032)
7.3.3 World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Next Generation Probiotics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceuticals and Biotherapy Industry
8.2.2 Dietary Supplements and Functional Foods Industry
8.2.3 Food and Beverage Industry
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Next Generation Probiotics Production by Application (2021-2032)
8.3.2 World Next Generation Probiotics Production Value by Application (2021-2032)
8.3.3 World Next Generation Probiotics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Seres Therapeutics (USA)
9.1.1 Seres Therapeutics (USA) Details
9.1.2 Seres Therapeutics (USA) Major Business
9.1.3 Seres Therapeutics (USA) Next Generation Probiotics Product and Services
9.1.4 Seres Therapeutics (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Seres Therapeutics (USA) Recent Developments/Updates
9.1.6 Seres Therapeutics (USA) Competitive Strengths & Weaknesses
9.2 Ferring Pharmaceuticals (Switzerland)
9.2.1 Ferring Pharmaceuticals (Switzerland) Details
9.2.2 Ferring Pharmaceuticals (Switzerland) Major Business
9.2.3 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product and Services
9.2.4 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Ferring Pharmaceuticals (Switzerland) Recent Developments/Updates
9.2.6 Ferring Pharmaceuticals (Switzerland) Competitive Strengths & Weaknesses
9.3 Vedanta Biosciences (USA)
9.3.1 Vedanta Biosciences (USA) Details
9.3.2 Vedanta Biosciences (USA) Major Business
9.3.3 Vedanta Biosciences (USA) Next Generation Probiotics Product and Services
9.3.4 Vedanta Biosciences (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Vedanta Biosciences (USA) Recent Developments/Updates
9.3.6 Vedanta Biosciences (USA) Competitive Strengths & Weaknesses
9.4 Enterome (France)
9.4.1 Enterome (France) Details
9.4.2 Enterome (France) Major Business
9.4.3 Enterome (France) Next Generation Probiotics Product and Services
9.4.4 Enterome (France) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Enterome (France) Recent Developments/Updates
9.4.6 Enterome (France) Competitive Strengths & Weaknesses
9.5 4D Pharma (UK)
9.5.1 4D Pharma (UK) Details
9.5.2 4D Pharma (UK) Major Business
9.5.3 4D Pharma (UK) Next Generation Probiotics Product and Services
9.5.4 4D Pharma (UK) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 4D Pharma (UK) Recent Developments/Updates
9.5.6 4D Pharma (UK) Competitive Strengths & Weaknesses
9.6 Second Genome (USA)
9.6.1 Second Genome (USA) Details
9.6.2 Second Genome (USA) Major Business
9.6.3 Second Genome (USA) Next Generation Probiotics Product and Services
9.6.4 Second Genome (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Second Genome (USA) Recent Developments/Updates
9.6.6 Second Genome (USA) Competitive Strengths & Weaknesses
9.7 AOBiome (USA)
9.7.1 AOBiome (USA) Details
9.7.2 AOBiome (USA) Major Business
9.7.3 AOBiome (USA) Next Generation Probiotics Product and Services
9.7.4 AOBiome (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 AOBiome (USA) Recent Developments/Updates
9.7.6 AOBiome (USA) Competitive Strengths & Weaknesses
9.8 Finch Therapeutics (USA)
9.8.1 Finch Therapeutics (USA) Details
9.8.2 Finch Therapeutics (USA) Major Business
9.8.3 Finch Therapeutics (USA) Next Generation Probiotics Product and Services
9.8.4 Finch Therapeutics (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Finch Therapeutics (USA) Recent Developments/Updates
9.8.6 Finch Therapeutics (USA) Competitive Strengths & Weaknesses
9.9 MaaT Pharma (France)
9.9.1 MaaT Pharma (France) Details
9.9.2 MaaT Pharma (France) Major Business
9.9.3 MaaT Pharma (France) Next Generation Probiotics Product and Services
9.9.4 MaaT Pharma (France) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 MaaT Pharma (France) Recent Developments/Updates
9.9.6 MaaT Pharma (France) Competitive Strengths & Weaknesses
9.10 BioGaia (Sweden)
9.10.1 BioGaia (Sweden) Details
9.10.2 BioGaia (Sweden) Major Business
9.10.3 BioGaia (Sweden) Next Generation Probiotics Product and Services
9.10.4 BioGaia (Sweden) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 BioGaia (Sweden) Recent Developments/Updates
9.10.6 BioGaia (Sweden) Competitive Strengths & Weaknesses
9.11 Yakult Honsha (Japan)
9.11.1 Yakult Honsha (Japan) Details
9.11.2 Yakult Honsha (Japan) Major Business
9.11.3 Yakult Honsha (Japan) Next Generation Probiotics Product and Services
9.11.4 Yakult Honsha (Japan) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Yakult Honsha (Japan) Recent Developments/Updates
9.11.6 Yakult Honsha (Japan) Competitive Strengths & Weaknesses
9.12 Morinaga Milk Industry (Japan)
9.12.1 Morinaga Milk Industry (Japan) Details
9.12.2 Morinaga Milk Industry (Japan) Major Business
9.12.3 Morinaga Milk Industry (Japan) Next Generation Probiotics Product and Services
9.12.4 Morinaga Milk Industry (Japan) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Morinaga Milk Industry (Japan) Recent Developments/Updates
9.12.6 Morinaga Milk Industry (Japan) Competitive Strengths & Weaknesses
9.13 DuPont (USA)
9.13.1 DuPont (USA) Details
9.13.2 DuPont (USA) Major Business
9.13.3 DuPont (USA) Next Generation Probiotics Product and Services
9.13.4 DuPont (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 DuPont (USA) Recent Developments/Updates
9.13.6 DuPont (USA) Competitive Strengths & Weaknesses
9.14 Chr. Hansen (Denmark)
9.14.1 Chr. Hansen (Denmark) Details
9.14.2 Chr. Hansen (Denmark) Major Business
9.14.3 Chr. Hansen (Denmark) Next Generation Probiotics Product and Services
9.14.4 Chr. Hansen (Denmark) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Chr. Hansen (Denmark) Recent Developments/Updates
9.14.6 Chr. Hansen (Denmark) Competitive Strengths & Weaknesses
9.15 Lallemand (Canada)
9.15.1 Lallemand (Canada) Details
9.15.2 Lallemand (Canada) Major Business
9.15.3 Lallemand (Canada) Next Generation Probiotics Product and Services
9.15.4 Lallemand (Canada) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Lallemand (Canada) Recent Developments/Updates
9.15.6 Lallemand (Canada) Competitive Strengths & Weaknesses
9.16 Probi (Sweden)
9.16.1 Probi (Sweden) Details
9.16.2 Probi (Sweden) Major Business
9.16.3 Probi (Sweden) Next Generation Probiotics Product and Services
9.16.4 Probi (Sweden) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Probi (Sweden) Recent Developments/Updates
9.16.6 Probi (Sweden) Competitive Strengths & Weaknesses
9.17 Novozymes (Denmark)
9.17.1 Novozymes (Denmark) Details
9.17.2 Novozymes (Denmark) Major Business
9.17.3 Novozymes (Denmark) Next Generation Probiotics Product and Services
9.17.4 Novozymes (Denmark) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Novozymes (Denmark) Recent Developments/Updates
9.17.6 Novozymes (Denmark) Competitive Strengths & Weaknesses
9.18 Kerry Group (Ireland)
9.18.1 Kerry Group (Ireland) Details
9.18.2 Kerry Group (Ireland) Major Business
9.18.3 Kerry Group (Ireland) Next Generation Probiotics Product and Services
9.18.4 Kerry Group (Ireland) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Kerry Group (Ireland) Recent Developments/Updates
9.18.6 Kerry Group (Ireland) Competitive Strengths & Weaknesses
9.19 ADM (USA)
9.19.1 ADM (USA) Details
9.19.2 ADM (USA) Major Business
9.19.3 ADM (USA) Next Generation Probiotics Product and Services
9.19.4 ADM (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 ADM (USA) Recent Developments/Updates
9.19.6 ADM (USA) Competitive Strengths & Weaknesses
9.20 BGI Genomics (China)
9.20.1 BGI Genomics (China) Details
9.20.2 BGI Genomics (China) Major Business
9.20.3 BGI Genomics (China) Next Generation Probiotics Product and Services
9.20.4 BGI Genomics (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 BGI Genomics (China) Recent Developments/Updates
9.20.6 BGI Genomics (China) Competitive Strengths & Weaknesses
9.21 Joinn Laboratories (China)
9.21.1 Joinn Laboratories (China) Details
9.21.2 Joinn Laboratories (China) Major Business
9.21.3 Joinn Laboratories (China) Next Generation Probiotics Product and Services
9.21.4 Joinn Laboratories (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Joinn Laboratories (China) Recent Developments/Updates
9.21.6 Joinn Laboratories (China) Competitive Strengths & Weaknesses
9.22 Jiangsu Wecare Probiotics (China)
9.22.1 Jiangsu Wecare Probiotics (China) Details
9.22.2 Jiangsu Wecare Probiotics (China) Major Business
9.22.3 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product and Services
9.22.4 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Wecare Probiotics (China) Recent Developments/Updates
9.22.6 Jiangsu Wecare Probiotics (China) Competitive Strengths & Weaknesses
9.23 Angel Yeast (China)
9.23.1 Angel Yeast (China) Details
9.23.2 Angel Yeast (China) Major Business
9.23.3 Angel Yeast (China) Next Generation Probiotics Product and Services
9.23.4 Angel Yeast (China) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Angel Yeast (China) Recent Developments/Updates
9.23.6 Angel Yeast (China) Competitive Strengths & Weaknesses
9.24 Evelo Biosciences (USA)
9.24.1 Evelo Biosciences (USA) Details
9.24.2 Evelo Biosciences (USA) Major Business
9.24.3 Evelo Biosciences (USA) Next Generation Probiotics Product and Services
9.24.4 Evelo Biosciences (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Evelo Biosciences (USA) Recent Developments/Updates
9.24.6 Evelo Biosciences (USA) Competitive Strengths & Weaknesses
9.25 BIFIDO (South Korea)
9.25.1 BIFIDO (South Korea) Details
9.25.2 BIFIDO (South Korea) Major Business
9.25.3 BIFIDO (South Korea) Next Generation Probiotics Product and Services
9.25.4 BIFIDO (South Korea) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 BIFIDO (South Korea) Recent Developments/Updates
9.25.6 BIFIDO (South Korea) Competitive Strengths & Weaknesses
9.26 Cell Biotech (South Korea)
9.26.1 Cell Biotech (South Korea) Details
9.26.2 Cell Biotech (South Korea) Major Business
9.26.3 Cell Biotech (South Korea) Next Generation Probiotics Product and Services
9.26.4 Cell Biotech (South Korea) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Cell Biotech (South Korea) Recent Developments/Updates
9.26.6 Cell Biotech (South Korea) Competitive Strengths & Weaknesses
9.27 Synlogic (USA)
9.27.1 Synlogic (USA) Details
9.27.2 Synlogic (USA) Major Business
9.27.3 Synlogic (USA) Next Generation Probiotics Product and Services
9.27.4 Synlogic (USA) Next Generation Probiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Synlogic (USA) Recent Developments/Updates
9.27.6 Synlogic (USA) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Next Generation Probiotics Industry Chain
10.2 Next Generation Probiotics Upstream Analysis
10.2.1 Next Generation Probiotics Core Raw Materials
10.2.2 Main Manufacturers of Next Generation Probiotics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Next Generation Probiotics Production Mode
10.6 Next Generation Probiotics Procurement Model
10.7 Next Generation Probiotics Industry Sales Model and Sales Channels
10.7.1 Next Generation Probiotics Sales Model
10.7.2 Next Generation Probiotics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Next Generation Probiotics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Next Generation Probiotics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Next Generation Probiotics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Next Generation Probiotics Production Value Market Share by Region (2021-2026)
Table 5. World Next Generation Probiotics Production Value Market Share by Region (2027-2032)
Table 6. World Next Generation Probiotics Production by Region (2021-2026) & (Tons)
Table 7. World Next Generation Probiotics Production by Region (2027-2032) & (Tons)
Table 8. World Next Generation Probiotics Production Market Share by Region (2021-2026)
Table 9. World Next Generation Probiotics Production Market Share by Region (2027-2032)
Table 10. World Next Generation Probiotics Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Next Generation Probiotics Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Next Generation Probiotics Major Market Trends
Table 13. World Next Generation Probiotics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Next Generation Probiotics Consumption by Region (2021-2026) & (Tons)
Table 15. World Next Generation Probiotics Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Next Generation Probiotics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Next Generation Probiotics Producers in 2025
Table 18. World Next Generation Probiotics Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Next Generation Probiotics Producers in 2025
Table 20. World Next Generation Probiotics Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Next Generation Probiotics Company Evaluation Quadrant
Table 22. World Next Generation Probiotics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Next Generation Probiotics Production Site of Key Manufacturer
Table 24. Next Generation Probiotics Market: Company Product Type Footprint
Table 25. Next Generation Probiotics Market: Company Product Application Footprint
Table 26. Next Generation Probiotics Competitive Factors
Table 27. Next Generation Probiotics New Entrant and Capacity Expansion Plans
Table 28. Next Generation Probiotics Mergers & Acquisitions Activity
Table 29. United States VS China Next Generation Probiotics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Next Generation Probiotics Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Next Generation Probiotics Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Next Generation Probiotics Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 37. China Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Next Generation Probiotics Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 42. Rest of World Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Next Generation Probiotics Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 47. World Next Generation Probiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Next Generation Probiotics Production by Type (2021-2026) & (Tons)
Table 49. World Next Generation Probiotics Production by Type (2027-2032) & (Tons)
Table 50. World Next Generation Probiotics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Next Generation Probiotics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Next Generation Probiotics Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Next Generation Probiotics Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Next Generation Probiotics Production Value by Live Bacteria Status, (USD Million), 2021 & 2025 & 2032
Table 55. World Next Generation Probiotics Production by Live Bacteria Status (2021-2026) & (Tons)
Table 56. World Next Generation Probiotics Production by Live Bacteria Status (2027-2032) & (Tons)
Table 57. World Next Generation Probiotics Production Value by Live Bacteria Status (2021-2026) & (USD Million)
Table 58. World Next Generation Probiotics Production Value by Live Bacteria Status (2027-2032) & (USD Million)
Table 59. World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2026) & (US$/Ton)
Table 60. World Next Generation Probiotics Average Price by Live Bacteria Status (2027-2032) & (US$/Ton)
Table 61. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions, (USD Million), 2021 & 2025 & 2032
Table 62. World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2021-2026) & (Tons)
Table 63. World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2027-2032) & (Tons)
Table 64. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2021-2026) & (USD Million)
Table 65. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2027-2032) & (USD Million)
Table 66. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2026) & (US$/Ton)
Table 67. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2027-2032) & (US$/Ton)
Table 68. World Next Generation Probiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Next Generation Probiotics Production by Application (2021-2026) & (Tons)
Table 70. World Next Generation Probiotics Production by Application (2027-2032) & (Tons)
Table 71. World Next Generation Probiotics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Next Generation Probiotics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Next Generation Probiotics Average Price by Application (2021-2026) & (US$/Ton)
Table 74. World Next Generation Probiotics Average Price by Application (2027-2032) & (US$/Ton)
Table 75. Seres Therapeutics (USA) Basic Information, Manufacturing Base and Competitors
Table 76. Seres Therapeutics (USA) Major Business
Table 77. Seres Therapeutics (USA) Next Generation Probiotics Product and Services
Table 78. Seres Therapeutics (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Seres Therapeutics (USA) Recent Developments/Updates
Table 80. Seres Therapeutics (USA) Competitive Strengths & Weaknesses
Table 81. Ferring Pharmaceuticals (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 82. Ferring Pharmaceuticals (Switzerland) Major Business
Table 83. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product and Services
Table 84. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Ferring Pharmaceuticals (Switzerland) Recent Developments/Updates
Table 86. Ferring Pharmaceuticals (Switzerland) Competitive Strengths & Weaknesses
Table 87. Vedanta Biosciences (USA) Basic Information, Manufacturing Base and Competitors
Table 88. Vedanta Biosciences (USA) Major Business
Table 89. Vedanta Biosciences (USA) Next Generation Probiotics Product and Services
Table 90. Vedanta Biosciences (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Vedanta Biosciences (USA) Recent Developments/Updates
Table 92. Vedanta Biosciences (USA) Competitive Strengths & Weaknesses
Table 93. Enterome (France) Basic Information, Manufacturing Base and Competitors
Table 94. Enterome (France) Major Business
Table 95. Enterome (France) Next Generation Probiotics Product and Services
Table 96. Enterome (France) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Enterome (France) Recent Developments/Updates
Table 98. Enterome (France) Competitive Strengths & Weaknesses
Table 99. 4D Pharma (UK) Basic Information, Manufacturing Base and Competitors
Table 100. 4D Pharma (UK) Major Business
Table 101. 4D Pharma (UK) Next Generation Probiotics Product and Services
Table 102. 4D Pharma (UK) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. 4D Pharma (UK) Recent Developments/Updates
Table 104. 4D Pharma (UK) Competitive Strengths & Weaknesses
Table 105. Second Genome (USA) Basic Information, Manufacturing Base and Competitors
Table 106. Second Genome (USA) Major Business
Table 107. Second Genome (USA) Next Generation Probiotics Product and Services
Table 108. Second Genome (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Second Genome (USA) Recent Developments/Updates
Table 110. Second Genome (USA) Competitive Strengths & Weaknesses
Table 111. AOBiome (USA) Basic Information, Manufacturing Base and Competitors
Table 112. AOBiome (USA) Major Business
Table 113. AOBiome (USA) Next Generation Probiotics Product and Services
Table 114. AOBiome (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. AOBiome (USA) Recent Developments/Updates
Table 116. AOBiome (USA) Competitive Strengths & Weaknesses
Table 117. Finch Therapeutics (USA) Basic Information, Manufacturing Base and Competitors
Table 118. Finch Therapeutics (USA) Major Business
Table 119. Finch Therapeutics (USA) Next Generation Probiotics Product and Services
Table 120. Finch Therapeutics (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Finch Therapeutics (USA) Recent Developments/Updates
Table 122. Finch Therapeutics (USA) Competitive Strengths & Weaknesses
Table 123. MaaT Pharma (France) Basic Information, Manufacturing Base and Competitors
Table 124. MaaT Pharma (France) Major Business
Table 125. MaaT Pharma (France) Next Generation Probiotics Product and Services
Table 126. MaaT Pharma (France) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. MaaT Pharma (France) Recent Developments/Updates
Table 128. MaaT Pharma (France) Competitive Strengths & Weaknesses
Table 129. BioGaia (Sweden) Basic Information, Manufacturing Base and Competitors
Table 130. BioGaia (Sweden) Major Business
Table 131. BioGaia (Sweden) Next Generation Probiotics Product and Services
Table 132. BioGaia (Sweden) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. BioGaia (Sweden) Recent Developments/Updates
Table 134. BioGaia (Sweden) Competitive Strengths & Weaknesses
Table 135. Yakult Honsha (Japan) Basic Information, Manufacturing Base and Competitors
Table 136. Yakult Honsha (Japan) Major Business
Table 137. Yakult Honsha (Japan) Next Generation Probiotics Product and Services
Table 138. Yakult Honsha (Japan) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Yakult Honsha (Japan) Recent Developments/Updates
Table 140. Yakult Honsha (Japan) Competitive Strengths & Weaknesses
Table 141. Morinaga Milk Industry (Japan) Basic Information, Manufacturing Base and Competitors
Table 142. Morinaga Milk Industry (Japan) Major Business
Table 143. Morinaga Milk Industry (Japan) Next Generation Probiotics Product and Services
Table 144. Morinaga Milk Industry (Japan) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Morinaga Milk Industry (Japan) Recent Developments/Updates
Table 146. Morinaga Milk Industry (Japan) Competitive Strengths & Weaknesses
Table 147. DuPont (USA) Basic Information, Manufacturing Base and Competitors
Table 148. DuPont (USA) Major Business
Table 149. DuPont (USA) Next Generation Probiotics Product and Services
Table 150. DuPont (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. DuPont (USA) Recent Developments/Updates
Table 152. DuPont (USA) Competitive Strengths & Weaknesses
Table 153. Chr. Hansen (Denmark) Basic Information, Manufacturing Base and Competitors
Table 154. Chr. Hansen (Denmark) Major Business
Table 155. Chr. Hansen (Denmark) Next Generation Probiotics Product and Services
Table 156. Chr. Hansen (Denmark) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Chr. Hansen (Denmark) Recent Developments/Updates
Table 158. Chr. Hansen (Denmark) Competitive Strengths & Weaknesses
Table 159. Lallemand (Canada) Basic Information, Manufacturing Base and Competitors
Table 160. Lallemand (Canada) Major Business
Table 161. Lallemand (Canada) Next Generation Probiotics Product and Services
Table 162. Lallemand (Canada) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Lallemand (Canada) Recent Developments/Updates
Table 164. Lallemand (Canada) Competitive Strengths & Weaknesses
Table 165. Probi (Sweden) Basic Information, Manufacturing Base and Competitors
Table 166. Probi (Sweden) Major Business
Table 167. Probi (Sweden) Next Generation Probiotics Product and Services
Table 168. Probi (Sweden) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Probi (Sweden) Recent Developments/Updates
Table 170. Probi (Sweden) Competitive Strengths & Weaknesses
Table 171. Novozymes (Denmark) Basic Information, Manufacturing Base and Competitors
Table 172. Novozymes (Denmark) Major Business
Table 173. Novozymes (Denmark) Next Generation Probiotics Product and Services
Table 174. Novozymes (Denmark) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Novozymes (Denmark) Recent Developments/Updates
Table 176. Novozymes (Denmark) Competitive Strengths & Weaknesses
Table 177. Kerry Group (Ireland) Basic Information, Manufacturing Base and Competitors
Table 178. Kerry Group (Ireland) Major Business
Table 179. Kerry Group (Ireland) Next Generation Probiotics Product and Services
Table 180. Kerry Group (Ireland) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Kerry Group (Ireland) Recent Developments/Updates
Table 182. Kerry Group (Ireland) Competitive Strengths & Weaknesses
Table 183. ADM (USA) Basic Information, Manufacturing Base and Competitors
Table 184. ADM (USA) Major Business
Table 185. ADM (USA) Next Generation Probiotics Product and Services
Table 186. ADM (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. ADM (USA) Recent Developments/Updates
Table 188. ADM (USA) Competitive Strengths & Weaknesses
Table 189. BGI Genomics (China) Basic Information, Manufacturing Base and Competitors
Table 190. BGI Genomics (China) Major Business
Table 191. BGI Genomics (China) Next Generation Probiotics Product and Services
Table 192. BGI Genomics (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. BGI Genomics (China) Recent Developments/Updates
Table 194. BGI Genomics (China) Competitive Strengths & Weaknesses
Table 195. Joinn Laboratories (China) Basic Information, Manufacturing Base and Competitors
Table 196. Joinn Laboratories (China) Major Business
Table 197. Joinn Laboratories (China) Next Generation Probiotics Product and Services
Table 198. Joinn Laboratories (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Joinn Laboratories (China) Recent Developments/Updates
Table 200. Joinn Laboratories (China) Competitive Strengths & Weaknesses
Table 201. Jiangsu Wecare Probiotics (China) Basic Information, Manufacturing Base and Competitors
Table 202. Jiangsu Wecare Probiotics (China) Major Business
Table 203. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product and Services
Table 204. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Jiangsu Wecare Probiotics (China) Recent Developments/Updates
Table 206. Jiangsu Wecare Probiotics (China) Competitive Strengths & Weaknesses
Table 207. Angel Yeast (China) Basic Information, Manufacturing Base and Competitors
Table 208. Angel Yeast (China) Major Business
Table 209. Angel Yeast (China) Next Generation Probiotics Product and Services
Table 210. Angel Yeast (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Angel Yeast (China) Recent Developments/Updates
Table 212. Angel Yeast (China) Competitive Strengths & Weaknesses
Table 213. Evelo Biosciences (USA) Basic Information, Manufacturing Base and Competitors
Table 214. Evelo Biosciences (USA) Major Business
Table 215. Evelo Biosciences (USA) Next Generation Probiotics Product and Services
Table 216. Evelo Biosciences (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Evelo Biosciences (USA) Recent Developments/Updates
Table 218. Evelo Biosciences (USA) Competitive Strengths & Weaknesses
Table 219. BIFIDO (South Korea) Basic Information, Manufacturing Base and Competitors
Table 220. BIFIDO (South Korea) Major Business
Table 221. BIFIDO (South Korea) Next Generation Probiotics Product and Services
Table 222. BIFIDO (South Korea) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. BIFIDO (South Korea) Recent Developments/Updates
Table 224. BIFIDO (South Korea) Competitive Strengths & Weaknesses
Table 225. Cell Biotech (South Korea) Basic Information, Manufacturing Base and Competitors
Table 226. Cell Biotech (South Korea) Major Business
Table 227. Cell Biotech (South Korea) Next Generation Probiotics Product and Services
Table 228. Cell Biotech (South Korea) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Cell Biotech (South Korea) Recent Developments/Updates
Table 230. Cell Biotech (South Korea) Competitive Strengths & Weaknesses
Table 231. Synlogic (USA) Basic Information, Manufacturing Base and Competitors
Table 232. Synlogic (USA) Major Business
Table 233. Synlogic (USA) Next Generation Probiotics Product and Services
Table 234. Synlogic (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Synlogic (USA) Recent Developments/Updates
Table 236. Synlogic (USA) Competitive Strengths & Weaknesses
Table 237. Global Key Players of Next Generation Probiotics Upstream (Raw Materials)
Table 238. Global Next Generation Probiotics Typical Customers
Table 239. Next Generation Probiotics Typical Distributors
Table 1. World Next Generation Probiotics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Next Generation Probiotics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Next Generation Probiotics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Next Generation Probiotics Production Value Market Share by Region (2021-2026)
Table 5. World Next Generation Probiotics Production Value Market Share by Region (2027-2032)
Table 6. World Next Generation Probiotics Production by Region (2021-2026) & (Tons)
Table 7. World Next Generation Probiotics Production by Region (2027-2032) & (Tons)
Table 8. World Next Generation Probiotics Production Market Share by Region (2021-2026)
Table 9. World Next Generation Probiotics Production Market Share by Region (2027-2032)
Table 10. World Next Generation Probiotics Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Next Generation Probiotics Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Next Generation Probiotics Major Market Trends
Table 13. World Next Generation Probiotics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Next Generation Probiotics Consumption by Region (2021-2026) & (Tons)
Table 15. World Next Generation Probiotics Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Next Generation Probiotics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Next Generation Probiotics Producers in 2025
Table 18. World Next Generation Probiotics Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Next Generation Probiotics Producers in 2025
Table 20. World Next Generation Probiotics Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Next Generation Probiotics Company Evaluation Quadrant
Table 22. World Next Generation Probiotics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Next Generation Probiotics Production Site of Key Manufacturer
Table 24. Next Generation Probiotics Market: Company Product Type Footprint
Table 25. Next Generation Probiotics Market: Company Product Application Footprint
Table 26. Next Generation Probiotics Competitive Factors
Table 27. Next Generation Probiotics New Entrant and Capacity Expansion Plans
Table 28. Next Generation Probiotics Mergers & Acquisitions Activity
Table 29. United States VS China Next Generation Probiotics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Next Generation Probiotics Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Next Generation Probiotics Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Next Generation Probiotics Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 37. China Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Next Generation Probiotics Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 42. Rest of World Based Next Generation Probiotics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Next Generation Probiotics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Next Generation Probiotics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Next Generation Probiotics Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Next Generation Probiotics Production Market Share (2021-2026)
Table 47. World Next Generation Probiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Next Generation Probiotics Production by Type (2021-2026) & (Tons)
Table 49. World Next Generation Probiotics Production by Type (2027-2032) & (Tons)
Table 50. World Next Generation Probiotics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Next Generation Probiotics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Next Generation Probiotics Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Next Generation Probiotics Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Next Generation Probiotics Production Value by Live Bacteria Status, (USD Million), 2021 & 2025 & 2032
Table 55. World Next Generation Probiotics Production by Live Bacteria Status (2021-2026) & (Tons)
Table 56. World Next Generation Probiotics Production by Live Bacteria Status (2027-2032) & (Tons)
Table 57. World Next Generation Probiotics Production Value by Live Bacteria Status (2021-2026) & (USD Million)
Table 58. World Next Generation Probiotics Production Value by Live Bacteria Status (2027-2032) & (USD Million)
Table 59. World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2026) & (US$/Ton)
Table 60. World Next Generation Probiotics Average Price by Live Bacteria Status (2027-2032) & (US$/Ton)
Table 61. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions, (USD Million), 2021 & 2025 & 2032
Table 62. World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2021-2026) & (Tons)
Table 63. World Next Generation Probiotics Production by Core Functional Targeting Dimensions (2027-2032) & (Tons)
Table 64. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2021-2026) & (USD Million)
Table 65. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions (2027-2032) & (USD Million)
Table 66. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2026) & (US$/Ton)
Table 67. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2027-2032) & (US$/Ton)
Table 68. World Next Generation Probiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Next Generation Probiotics Production by Application (2021-2026) & (Tons)
Table 70. World Next Generation Probiotics Production by Application (2027-2032) & (Tons)
Table 71. World Next Generation Probiotics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Next Generation Probiotics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Next Generation Probiotics Average Price by Application (2021-2026) & (US$/Ton)
Table 74. World Next Generation Probiotics Average Price by Application (2027-2032) & (US$/Ton)
Table 75. Seres Therapeutics (USA) Basic Information, Manufacturing Base and Competitors
Table 76. Seres Therapeutics (USA) Major Business
Table 77. Seres Therapeutics (USA) Next Generation Probiotics Product and Services
Table 78. Seres Therapeutics (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Seres Therapeutics (USA) Recent Developments/Updates
Table 80. Seres Therapeutics (USA) Competitive Strengths & Weaknesses
Table 81. Ferring Pharmaceuticals (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 82. Ferring Pharmaceuticals (Switzerland) Major Business
Table 83. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product and Services
Table 84. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Ferring Pharmaceuticals (Switzerland) Recent Developments/Updates
Table 86. Ferring Pharmaceuticals (Switzerland) Competitive Strengths & Weaknesses
Table 87. Vedanta Biosciences (USA) Basic Information, Manufacturing Base and Competitors
Table 88. Vedanta Biosciences (USA) Major Business
Table 89. Vedanta Biosciences (USA) Next Generation Probiotics Product and Services
Table 90. Vedanta Biosciences (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Vedanta Biosciences (USA) Recent Developments/Updates
Table 92. Vedanta Biosciences (USA) Competitive Strengths & Weaknesses
Table 93. Enterome (France) Basic Information, Manufacturing Base and Competitors
Table 94. Enterome (France) Major Business
Table 95. Enterome (France) Next Generation Probiotics Product and Services
Table 96. Enterome (France) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Enterome (France) Recent Developments/Updates
Table 98. Enterome (France) Competitive Strengths & Weaknesses
Table 99. 4D Pharma (UK) Basic Information, Manufacturing Base and Competitors
Table 100. 4D Pharma (UK) Major Business
Table 101. 4D Pharma (UK) Next Generation Probiotics Product and Services
Table 102. 4D Pharma (UK) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. 4D Pharma (UK) Recent Developments/Updates
Table 104. 4D Pharma (UK) Competitive Strengths & Weaknesses
Table 105. Second Genome (USA) Basic Information, Manufacturing Base and Competitors
Table 106. Second Genome (USA) Major Business
Table 107. Second Genome (USA) Next Generation Probiotics Product and Services
Table 108. Second Genome (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Second Genome (USA) Recent Developments/Updates
Table 110. Second Genome (USA) Competitive Strengths & Weaknesses
Table 111. AOBiome (USA) Basic Information, Manufacturing Base and Competitors
Table 112. AOBiome (USA) Major Business
Table 113. AOBiome (USA) Next Generation Probiotics Product and Services
Table 114. AOBiome (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. AOBiome (USA) Recent Developments/Updates
Table 116. AOBiome (USA) Competitive Strengths & Weaknesses
Table 117. Finch Therapeutics (USA) Basic Information, Manufacturing Base and Competitors
Table 118. Finch Therapeutics (USA) Major Business
Table 119. Finch Therapeutics (USA) Next Generation Probiotics Product and Services
Table 120. Finch Therapeutics (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Finch Therapeutics (USA) Recent Developments/Updates
Table 122. Finch Therapeutics (USA) Competitive Strengths & Weaknesses
Table 123. MaaT Pharma (France) Basic Information, Manufacturing Base and Competitors
Table 124. MaaT Pharma (France) Major Business
Table 125. MaaT Pharma (France) Next Generation Probiotics Product and Services
Table 126. MaaT Pharma (France) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. MaaT Pharma (France) Recent Developments/Updates
Table 128. MaaT Pharma (France) Competitive Strengths & Weaknesses
Table 129. BioGaia (Sweden) Basic Information, Manufacturing Base and Competitors
Table 130. BioGaia (Sweden) Major Business
Table 131. BioGaia (Sweden) Next Generation Probiotics Product and Services
Table 132. BioGaia (Sweden) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. BioGaia (Sweden) Recent Developments/Updates
Table 134. BioGaia (Sweden) Competitive Strengths & Weaknesses
Table 135. Yakult Honsha (Japan) Basic Information, Manufacturing Base and Competitors
Table 136. Yakult Honsha (Japan) Major Business
Table 137. Yakult Honsha (Japan) Next Generation Probiotics Product and Services
Table 138. Yakult Honsha (Japan) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Yakult Honsha (Japan) Recent Developments/Updates
Table 140. Yakult Honsha (Japan) Competitive Strengths & Weaknesses
Table 141. Morinaga Milk Industry (Japan) Basic Information, Manufacturing Base and Competitors
Table 142. Morinaga Milk Industry (Japan) Major Business
Table 143. Morinaga Milk Industry (Japan) Next Generation Probiotics Product and Services
Table 144. Morinaga Milk Industry (Japan) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Morinaga Milk Industry (Japan) Recent Developments/Updates
Table 146. Morinaga Milk Industry (Japan) Competitive Strengths & Weaknesses
Table 147. DuPont (USA) Basic Information, Manufacturing Base and Competitors
Table 148. DuPont (USA) Major Business
Table 149. DuPont (USA) Next Generation Probiotics Product and Services
Table 150. DuPont (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. DuPont (USA) Recent Developments/Updates
Table 152. DuPont (USA) Competitive Strengths & Weaknesses
Table 153. Chr. Hansen (Denmark) Basic Information, Manufacturing Base and Competitors
Table 154. Chr. Hansen (Denmark) Major Business
Table 155. Chr. Hansen (Denmark) Next Generation Probiotics Product and Services
Table 156. Chr. Hansen (Denmark) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Chr. Hansen (Denmark) Recent Developments/Updates
Table 158. Chr. Hansen (Denmark) Competitive Strengths & Weaknesses
Table 159. Lallemand (Canada) Basic Information, Manufacturing Base and Competitors
Table 160. Lallemand (Canada) Major Business
Table 161. Lallemand (Canada) Next Generation Probiotics Product and Services
Table 162. Lallemand (Canada) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Lallemand (Canada) Recent Developments/Updates
Table 164. Lallemand (Canada) Competitive Strengths & Weaknesses
Table 165. Probi (Sweden) Basic Information, Manufacturing Base and Competitors
Table 166. Probi (Sweden) Major Business
Table 167. Probi (Sweden) Next Generation Probiotics Product and Services
Table 168. Probi (Sweden) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Probi (Sweden) Recent Developments/Updates
Table 170. Probi (Sweden) Competitive Strengths & Weaknesses
Table 171. Novozymes (Denmark) Basic Information, Manufacturing Base and Competitors
Table 172. Novozymes (Denmark) Major Business
Table 173. Novozymes (Denmark) Next Generation Probiotics Product and Services
Table 174. Novozymes (Denmark) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Novozymes (Denmark) Recent Developments/Updates
Table 176. Novozymes (Denmark) Competitive Strengths & Weaknesses
Table 177. Kerry Group (Ireland) Basic Information, Manufacturing Base and Competitors
Table 178. Kerry Group (Ireland) Major Business
Table 179. Kerry Group (Ireland) Next Generation Probiotics Product and Services
Table 180. Kerry Group (Ireland) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Kerry Group (Ireland) Recent Developments/Updates
Table 182. Kerry Group (Ireland) Competitive Strengths & Weaknesses
Table 183. ADM (USA) Basic Information, Manufacturing Base and Competitors
Table 184. ADM (USA) Major Business
Table 185. ADM (USA) Next Generation Probiotics Product and Services
Table 186. ADM (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. ADM (USA) Recent Developments/Updates
Table 188. ADM (USA) Competitive Strengths & Weaknesses
Table 189. BGI Genomics (China) Basic Information, Manufacturing Base and Competitors
Table 190. BGI Genomics (China) Major Business
Table 191. BGI Genomics (China) Next Generation Probiotics Product and Services
Table 192. BGI Genomics (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. BGI Genomics (China) Recent Developments/Updates
Table 194. BGI Genomics (China) Competitive Strengths & Weaknesses
Table 195. Joinn Laboratories (China) Basic Information, Manufacturing Base and Competitors
Table 196. Joinn Laboratories (China) Major Business
Table 197. Joinn Laboratories (China) Next Generation Probiotics Product and Services
Table 198. Joinn Laboratories (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Joinn Laboratories (China) Recent Developments/Updates
Table 200. Joinn Laboratories (China) Competitive Strengths & Weaknesses
Table 201. Jiangsu Wecare Probiotics (China) Basic Information, Manufacturing Base and Competitors
Table 202. Jiangsu Wecare Probiotics (China) Major Business
Table 203. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product and Services
Table 204. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Jiangsu Wecare Probiotics (China) Recent Developments/Updates
Table 206. Jiangsu Wecare Probiotics (China) Competitive Strengths & Weaknesses
Table 207. Angel Yeast (China) Basic Information, Manufacturing Base and Competitors
Table 208. Angel Yeast (China) Major Business
Table 209. Angel Yeast (China) Next Generation Probiotics Product and Services
Table 210. Angel Yeast (China) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Angel Yeast (China) Recent Developments/Updates
Table 212. Angel Yeast (China) Competitive Strengths & Weaknesses
Table 213. Evelo Biosciences (USA) Basic Information, Manufacturing Base and Competitors
Table 214. Evelo Biosciences (USA) Major Business
Table 215. Evelo Biosciences (USA) Next Generation Probiotics Product and Services
Table 216. Evelo Biosciences (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Evelo Biosciences (USA) Recent Developments/Updates
Table 218. Evelo Biosciences (USA) Competitive Strengths & Weaknesses
Table 219. BIFIDO (South Korea) Basic Information, Manufacturing Base and Competitors
Table 220. BIFIDO (South Korea) Major Business
Table 221. BIFIDO (South Korea) Next Generation Probiotics Product and Services
Table 222. BIFIDO (South Korea) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. BIFIDO (South Korea) Recent Developments/Updates
Table 224. BIFIDO (South Korea) Competitive Strengths & Weaknesses
Table 225. Cell Biotech (South Korea) Basic Information, Manufacturing Base and Competitors
Table 226. Cell Biotech (South Korea) Major Business
Table 227. Cell Biotech (South Korea) Next Generation Probiotics Product and Services
Table 228. Cell Biotech (South Korea) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Cell Biotech (South Korea) Recent Developments/Updates
Table 230. Cell Biotech (South Korea) Competitive Strengths & Weaknesses
Table 231. Synlogic (USA) Basic Information, Manufacturing Base and Competitors
Table 232. Synlogic (USA) Major Business
Table 233. Synlogic (USA) Next Generation Probiotics Product and Services
Table 234. Synlogic (USA) Next Generation Probiotics Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Synlogic (USA) Recent Developments/Updates
Table 236. Synlogic (USA) Competitive Strengths & Weaknesses
Table 237. Global Key Players of Next Generation Probiotics Upstream (Raw Materials)
Table 238. Global Next Generation Probiotics Typical Customers
Table 239. Next Generation Probiotics Typical Distributors
LIST OF FIGURES
Figure 1. Next Generation Probiotics Picture
Figure 2. World Next Generation Probiotics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Next Generation Probiotics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 5. World Next Generation Probiotics Average Price (2021-2032) & (US$/Ton)
Figure 6. World Next Generation Probiotics Production Value Market Share by Region (2021-2032)
Figure 7. World Next Generation Probiotics Production Market Share by Region (2021-2032)
Figure 8. North America Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 9. Europe Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 10. China Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 11. Japan Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 12. Next Generation Probiotics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 15. World Next Generation Probiotics Consumption Market Share by Region (2021-2032)
Figure 16. United States Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 17. China Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 18. Europe Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 19. Japan Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 20. South Korea Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 22. India Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Next Generation Probiotics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Next Generation Probiotics Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Next Generation Probiotics Markets in 2025
Figure 26. United States VS China: Next Generation Probiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Next Generation Probiotics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Next Generation Probiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 30. China Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 32. World Next Generation Probiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Next Generation Probiotics Production Value Market Share by Type in 2025
Figure 34. Akkermansia
Figure 35. Clostridium Species
Figure 36. Bifidobacterium Species
Figure 37. Others
Figure 38. World Next Generation Probiotics Production Market Share by Type (2021-2032)
Figure 39. World Next Generation Probiotics Production Value Market Share by Type (2021-2032)
Figure 40. World Next Generation Probiotics Average Price by Type (2021-2032) & (US$/Ton)
Figure 41. World Next Generation Probiotics Production Value by Live Bacteria Status, (USD Million), 2021 & 2025 & 2032
Figure 42. World Next Generation Probiotics Production Value Market Share by Live Bacteria Status in 2025
Figure 43. Live NGP
Figure 44. Inactivated NGP
Figure 45. Others
Figure 46. World Next Generation Probiotics Production Market Share by Live Bacteria Status (2021-2032)
Figure 47. World Next Generation Probiotics Production Value Market Share by Live Bacteria Status (2021-2032)
Figure 48. World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2032) & (US$/Ton)
Figure 49. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions, (USD Million), 2021 & 2025 & 2032
Figure 50. World Next Generation Probiotics Production Value Market Share by Core Functional Targeting Dimensions in 2025
Figure 51. Metabolic Health Targeted Therapy
Figure 52. Intestinal Inflammation Targeted Therapy
Figure 53. Immune Regulation Targeted Therapy
Figure 54. Others
Figure 55. World Next Generation Probiotics Production Market Share by Core Functional Targeting Dimensions (2021-2032)
Figure 56. World Next Generation Probiotics Production Value Market Share by Core Functional Targeting Dimensions (2021-2032)
Figure 57. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2032) & (US$/Ton)
Figure 58. World Next Generation Probiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Next Generation Probiotics Production Value Market Share by Application in 2025
Figure 60. Pharmaceuticals and Biotherapy Industry
Figure 61. Dietary Supplements and Functional Foods Industry
Figure 62. Food and Beverage Industry
Figure 63. Others
Figure 64. World Next Generation Probiotics Production Market Share by Application (2021-2032)
Figure 65. World Next Generation Probiotics Production Value Market Share by Application (2021-2032)
Figure 66. World Next Generation Probiotics Average Price by Application (2021-2032) & (US$/Ton)
Figure 67. Next Generation Probiotics Industry Chain
Figure 68. Next Generation Probiotics Procurement Model
Figure 69. Next Generation Probiotics Sales Model
Figure 70. Next Generation Probiotics Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Next Generation Probiotics Picture
Figure 2. World Next Generation Probiotics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Next Generation Probiotics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 5. World Next Generation Probiotics Average Price (2021-2032) & (US$/Ton)
Figure 6. World Next Generation Probiotics Production Value Market Share by Region (2021-2032)
Figure 7. World Next Generation Probiotics Production Market Share by Region (2021-2032)
Figure 8. North America Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 9. Europe Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 10. China Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 11. Japan Next Generation Probiotics Production (2021-2032) & (Tons)
Figure 12. Next Generation Probiotics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 15. World Next Generation Probiotics Consumption Market Share by Region (2021-2032)
Figure 16. United States Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 17. China Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 18. Europe Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 19. Japan Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 20. South Korea Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 22. India Next Generation Probiotics Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Next Generation Probiotics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Next Generation Probiotics Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Next Generation Probiotics Markets in 2025
Figure 26. United States VS China: Next Generation Probiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Next Generation Probiotics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Next Generation Probiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 30. China Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Next Generation Probiotics Production Market Share 2025
Figure 32. World Next Generation Probiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Next Generation Probiotics Production Value Market Share by Type in 2025
Figure 34. Akkermansia
Figure 35. Clostridium Species
Figure 36. Bifidobacterium Species
Figure 37. Others
Figure 38. World Next Generation Probiotics Production Market Share by Type (2021-2032)
Figure 39. World Next Generation Probiotics Production Value Market Share by Type (2021-2032)
Figure 40. World Next Generation Probiotics Average Price by Type (2021-2032) & (US$/Ton)
Figure 41. World Next Generation Probiotics Production Value by Live Bacteria Status, (USD Million), 2021 & 2025 & 2032
Figure 42. World Next Generation Probiotics Production Value Market Share by Live Bacteria Status in 2025
Figure 43. Live NGP
Figure 44. Inactivated NGP
Figure 45. Others
Figure 46. World Next Generation Probiotics Production Market Share by Live Bacteria Status (2021-2032)
Figure 47. World Next Generation Probiotics Production Value Market Share by Live Bacteria Status (2021-2032)
Figure 48. World Next Generation Probiotics Average Price by Live Bacteria Status (2021-2032) & (US$/Ton)
Figure 49. World Next Generation Probiotics Production Value by Core Functional Targeting Dimensions, (USD Million), 2021 & 2025 & 2032
Figure 50. World Next Generation Probiotics Production Value Market Share by Core Functional Targeting Dimensions in 2025
Figure 51. Metabolic Health Targeted Therapy
Figure 52. Intestinal Inflammation Targeted Therapy
Figure 53. Immune Regulation Targeted Therapy
Figure 54. Others
Figure 55. World Next Generation Probiotics Production Market Share by Core Functional Targeting Dimensions (2021-2032)
Figure 56. World Next Generation Probiotics Production Value Market Share by Core Functional Targeting Dimensions (2021-2032)
Figure 57. World Next Generation Probiotics Average Price by Core Functional Targeting Dimensions (2021-2032) & (US$/Ton)
Figure 58. World Next Generation Probiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Next Generation Probiotics Production Value Market Share by Application in 2025
Figure 60. Pharmaceuticals and Biotherapy Industry
Figure 61. Dietary Supplements and Functional Foods Industry
Figure 62. Food and Beverage Industry
Figure 63. Others
Figure 64. World Next Generation Probiotics Production Market Share by Application (2021-2032)
Figure 65. World Next Generation Probiotics Production Value Market Share by Application (2021-2032)
Figure 66. World Next Generation Probiotics Average Price by Application (2021-2032) & (US$/Ton)
Figure 67. Next Generation Probiotics Industry Chain
Figure 68. Next Generation Probiotics Procurement Model
Figure 69. Next Generation Probiotics Sales Model
Figure 70. Next Generation Probiotics Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
